Agencies Experience, Boutique Approach
Want to accelerate your drug development process?
Welcome to Voisin Consulting Life Sciences
VCLS supports life science companies throughout product development, and engages in communication with regulators and payers. We partner with Biotech, Pharma and Medtech manufacturers to develop, register and launch innovative products in North American and European markets.
Through a network of partners, we also assist clients in Southeast Asia, Latin America, and a number of additional markets. We provide people-powered solutions to complement our clients’ in-house resources, from product development strategy, communication with regulators and payers up to market authorization and reimbursement.
Regulatory & Health Economics Expert Resources
All news & events
Latest News & Events
-
ARM CMC Summit
The ARM S&T Committee is hosting its 3rd annual CMC Summit to explore manufacturing and analytical challenges specific to the... -
VCLS Acquires IWA Consulting ApS to Further Strengthen its Capacities in the Northern Europe
Voisin Consulting Life Sciences (VCLS), a leading global HealthTech product development consultancy firm, today announced that it... -
Exclusive Interview with Biotech Finance: Biotechs and medtech, refine your pricing strategy and don’t work in silo!
Emmanuelle Voisin, Founder, and CEO of Voisin Consulting Life Sciences is an expert in regulatory sciences and market access. In...
All resources
Latest Resources
-
A Regulatory Landscape Shift for In Silico Clinical Trials
Modelling and simulation (M&S) has grown to become a reliable approach to better understand and optimise key decisions... -
Cell and Gene Therapies: European View on Challenges in Translation and How to Address Them
Advanced therapy medicinal products (ATMPs), i.e., cell and gene therapy products, is a rapidly evolving field of therapeutic... -
Unlocking the EMA Meetings: the Process and How to Prepare Adequately
Clear strategy, compelling argument and well-rehearsed preparation are the keys to winning at an EMA meeting, no matter if it is...